Singapore recalls three versions of diabetes drug metformin

LONDON (Bloomberg): Singapore health officials have recalled three of 46 versions of the diabetes drug metformin after finding amounts of a cancer-causing substance that was "above the acceptable level".

The recalled drugs had been sold locally for only a short time, and the risk to patients who had taken them is low, Singapore's Health Sciences Authority said in a statement.